LPC
HZNP

Lone Pine Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Lone Pine Capital’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,997,232
Closed -$232M – 45
2016
Q1 		$232M Sell
13,997,232
-1,603,756
-10% -$28.1M 1.18% 31
2015
Q4 		$338M Hold
15,600,988
– – 1.51% 28
2015
Q3 		$309M Buy
15,600,988
+12,396,016
+387% +$392M 1.38% 31
2015
Q2 		$111M Buy
+3,204,972
New +$97.8M 0.49% 46

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return